rs143090653

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001375808.2(LPIN2):​c.1867C>T​(p.Pro623Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00158 in 1,614,160 control chromosomes in the GnomAD database, including 40 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P623L) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0081 ( 20 hom., cov: 32)
Exomes 𝑓: 0.00090 ( 20 hom. )

Consequence

LPIN2
NM_001375808.2 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 2.53

Publications

5 publications found
Variant links:
Genes affected
LPIN2 (HGNC:14450): (lipin 2) Mouse studies suggest that this gene functions during normal adipose tissue development and may play a role in human triglyceride metabolism. This gene represents a candidate gene for human lipodystrophy, characterized by loss of body fat, fatty liver, hypertriglyceridemia, and insulin resistance. [provided by RefSeq, Jul 2008]
LPIN2 Gene-Disease associations (from GenCC):
  • Majeed syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.002999276).
BP6
Variant 18-2925295-G-A is Benign according to our data. Variant chr18-2925295-G-A is described in ClinVar as [Benign]. Clinvar id is 245641.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00811 (1235/152288) while in subpopulation AFR AF = 0.0283 (1177/41554). AF 95% confidence interval is 0.027. There are 20 homozygotes in GnomAd4. There are 571 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 20 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LPIN2NM_001375808.2 linkc.1867C>T p.Pro623Ser missense_variant Exon 14 of 20 ENST00000677752.1 NP_001362737.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LPIN2ENST00000677752.1 linkc.1867C>T p.Pro623Ser missense_variant Exon 14 of 20 NM_001375808.2 ENSP00000504857.1 Q92539

Frequencies

GnomAD3 genomes
AF:
0.00809
AC:
1231
AN:
152170
Hom.:
20
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0283
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00209
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.0000942
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000162
Gnomad OTH
AF:
0.00621
GnomAD2 exomes
AF:
0.00206
AC:
519
AN:
251494
AF XY:
0.00156
show subpopulations
Gnomad AFR exome
AF:
0.0277
Gnomad AMR exome
AF:
0.00136
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000462
Gnomad NFE exome
AF:
0.000149
Gnomad OTH exome
AF:
0.000651
GnomAD4 exome
AF:
0.000904
AC:
1322
AN:
1461872
Hom.:
20
Cov.:
32
AF XY:
0.000793
AC XY:
577
AN XY:
727238
show subpopulations
African (AFR)
AF:
0.0294
AC:
985
AN:
33480
American (AMR)
AF:
0.00143
AC:
64
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000696
AC:
6
AN:
86256
European-Finnish (FIN)
AF:
0.0000749
AC:
4
AN:
53420
Middle Eastern (MID)
AF:
0.00433
AC:
25
AN:
5768
European-Non Finnish (NFE)
AF:
0.000103
AC:
114
AN:
1111996
Other (OTH)
AF:
0.00205
AC:
124
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
76
152
229
305
381
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00811
AC:
1235
AN:
152288
Hom.:
20
Cov.:
32
AF XY:
0.00767
AC XY:
571
AN XY:
74458
show subpopulations
African (AFR)
AF:
0.0283
AC:
1177
AN:
41554
American (AMR)
AF:
0.00209
AC:
32
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4826
European-Finnish (FIN)
AF:
0.0000942
AC:
1
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000162
AC:
11
AN:
68014
Other (OTH)
AF:
0.00615
AC:
13
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
62
124
187
249
311
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00311
Hom.:
15
Bravo
AF:
0.00914
ESP6500AA
AF:
0.0259
AC:
114
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.00262
AC:
318
Asia WGS
AF:
0.00260
AC:
9
AN:
3478
EpiCase
AF:
0.000273
EpiControl
AF:
0.0000593

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Majeed syndrome Benign:2
Oct 16, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Oct 19, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Autoinflammatory syndrome Benign:1
May 03, 2022
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.074
BayesDel_addAF
Benign
-0.57
T
BayesDel_noAF
Benign
-0.57
CADD
Benign
9.8
DANN
Benign
0.34
DEOGEN2
Benign
0.040
T
Eigen
Benign
-0.89
Eigen_PC
Benign
-0.86
FATHMM_MKL
Uncertain
0.84
D
LIST_S2
Benign
0.64
T
MetaRNN
Benign
0.0030
T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
0.55
N
PhyloP100
2.5
PrimateAI
Benign
0.30
T
PROVEAN
Benign
-0.50
N
REVEL
Benign
0.15
Sift
Benign
0.80
T
Sift4G
Benign
0.40
T
Polyphen
0.0
B
Vest4
0.20
MVP
0.15
MPC
0.24
ClinPred
0.0014
T
GERP RS
0.89
Varity_R
0.017
gMVP
0.38
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.070
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs143090653; hg19: chr18-2925293; API